Clinical observation of Shihu Yiwei Fang in improving gastric mucosa erosion in patients with chronic non-atrophic gastritis (Weiyin Buzu syndrome)

Affiliated Hospital of Changchun University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Meeting the Western diagnostic criteria for chronic non-atrophic gastritis with erosion.
•(2) It meets the standard of TCM diagnosis of Weiyin Buzu syndrome.
•(3) Age 18-70 (including 18 and 70).

•(1) Patients with gastric and duodenal ulcers, gastritis with active bleeding, atrophic gastritis, gastric mucosal dysplasia or suspected malignant change by pathological diagnosis. Patients with gastrointestinal bleeding or after gastric surgery.
•(2) Combined with cardiovascular, cerebrovascular, liver, kidney, endocrine, hematopoietic system and other serious primary diseases, as well as other diseases other than chronic non-atrophic gastritis that affect the experimental drug observation.
•(3) Taking proton pump inhibitors, bismuth, antibiotics and other drugs that affect the efficacy observation within one month.
•(4) Helicobacter pylori infection.
•(5) Women who are pregnant or recently preparing to become pregnant, breast-feeding women.
•(6) Allergic constitution or components of the drug.
•(7) Participate in other clinical trials within 3 months.

发起方

Affiliated Hospital of Changchun University of Traditional Chinese Medicine